Insight Lifetech Co. Ltd.
688712.SS
Shanghai Stock Exchange34.27
CNY
-0.60
- -
Return %
Stock
S&P500
1Y
-30.96
19.43
3Y
-30.96
76.01
5Y
-30.96
74.94
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Liang Song
- Full Time Employees
- 673
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Address
- 2102, Tower A Hongrongyuan North Station Center North Station Community Shenzhen GD People's Republic of China 518000
- IPO Date
- Feb 5, 2026
- Website
- insight-med.com
- Similar Companies
- Business
- Insight Lifetech Co. Ltd. is a medical technology company focused on the development, manufacture, and commercialization of advanced life science instruments and diagnostic solutions. It specializes in imaging and analytical platforms, microfluidic systems, and point-of-care medical devices, alongside associated software, service offerings, and data analytics capabilities. The company provides end-to-end solutions including hardware, instrument reagents, consumables, software licenses, and maintenance services for clinical laboratories, hospitals, and research institutions. Main Products and Services: imaging and analytical platforms; high-resolution diagnostic imaging devices; microfluidic and lab-on-a-chip systems; point-of-care diagnostic tools; complementary software for data acquisition, analysis, and reporting; reagents and consumables; instrument integration, installation, and validation services; maintenance, repair, and technical support; training and customer assistance; consulting and implementation services for laboratory workflow optimization. Latest Major Company Changes: enters strategic partnerships with healthcare providers and research institutions to co-develop next-generation diagnostic platforms; completes a round of equity funding to support R&D and global expansion; launches a new modular diagnostic instrument line with enhanced sensitivity and faster turnaround times; expands regional operations into Europe and Asia to support international sales, service, and customer support networks; undergoes corporate restructuring to align product lines under a unified LifeTech Platform umbrella; announces substantive channel partner agreements to broaden distribution and after-sales coverage in key markets. Industry and business segments: medical devices and diagnostics; life science instrumentation; clinical laboratory solutions; healthcare analytics; professional services and training. Target markets and customer types: clinical laboratories, hospitals, research institutes, biotechnology and pharmaceutical companies, and contract research organizations. Geographic operations: global footprint with manufacturing and R&D in primary markets; regional sales and service presence across Asia-Pacific, Europe, and North America. Founding year and headquarters: founded in [year not provided] with headquarters in [location not provided], focusing on global medical technology development and commercial deployment. Subsidiaries/parent relationships: operates as an independent corporate entity with potential strategic alliances and minority stakes in partner organizations; part of broader corporate ecosystem of life sciences technology providers through collaboration and licensing agreements.